Quarterly report pursuant to Section 13 or 15(d)

NUVILEX, INC. CONSOLIDATED STATEMENTS OF OPERATIONS

 v2.3.0.11
NUVILEX, INC. CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
3 Months Ended
Jul. 31, 2011
Jul. 31, 2010
Revenues    
Product sales $ 19,762 $ 26,960
Total revenue 19,762 26,960
Cost of revenues 15,675 6,927
Gross profit 4,087 20,033
Expenses    
Sales and marketing 125,130 7,000
Compensation expense 305,564 0
Legal & professional fees 59,954 26,139
General and administrative 166,039 66,230
Total operating expenses 656,687 99,369
Net loss from operations (652,600) (79,336)
Other income (expense)    
Interest expense (33,420) (54,924)
Total other expense (33,420) (54,924)
Net loss $ (686,020) $ (134,260)
Basic loss per share $ 0.00 $ 0.00
Weighted average shares outstanding 367,294,646 348,387,581